Democratizing Drug Discovery

Crowdsourcing Drug Discovery

VivaMed brings together citizen scientists, AI researchers, and pharmaceutical partners to accelerate the invention of life-saving medicines — powered by world-class data and tools.

The VivaMed Ecosystem

Integrating data, innovation, and pharmaceutical partnerships

Comprehensive Biomedical Data

BioAtlas provides 0M+ rows of integrated genetics, drug, disease, and mechanism data — the foundation for breakthrough discoveries.

Explore BioAtlas

Global Innovation Network

BioVentures connects computational drug discoveries with commercialization opportunities — rewarding innovators with up to $0M per breakthrough.

Explore BioVentures

Pharmaceutical Partnerships

Strategic pharma partnerships accelerate validation and commercialization — turning computational predictions into clinical reality.

Become a Partner

Trusted by Leading Institutions

Partner 1
Partner 2
Partner 3
Partner 4
Partner 5
Partner 6
Partner 7
Partner 8
Partner 9
Partner 10
Partner 11
Partner 12
Partner 1
Partner 2
Partner 3
Partner 4
Partner 5
Partner 6
Partner 7
Partner 8
Partner 9
Partner 10
Partner 11
Partner 12

How It Works

From data integration to pharmaceutical partnerships — a proven pathway

1

BioAtlas

Biomedical data platform

2

Innovators

Computational discoveries

3

Validation

CRO partnerships

4

Pharma

Licensing & commercialization

BioAtlas

The world's most comprehensive biomedical knowledge base. 0M+ rows of integrated genetics, drugs, diseases, and mechanisms — free and open.

0M+ perturbations · 0M+ colocalizations · 40+ sources
Explore Data

BioVentures

Submit computational drug discoveries and share in commercial success. Innovators earn up to 10% of revenue, capped at $0M per breakthrough.

90-day evaluation · 10% revenue share · IP reversion
Learn More

VivaMed

Infrastructure for drug discovery commercialization. We handle IP protection, validation partnerships, and pharmaceutical licensing.

0+ drug assets · 39 approvals · Global network
About Us